Royal College of Surgeons of Edinburgh launches MRCS ophthalmology exam, Fellowship to follow

Article

A new MRCS ophthalmology examination will be offered to ICO College Members beginning in 2022.

Royal College of Surgeons of Edinburgh launches MRCS ophthalmology exam, Fellowship to follow

The Royal College of Surgeons of Edinburgh (RCSEd), a leading surgical college, announced the launch of its own Membership of the Royal College of Surgeons (MRCS) ophthalmology examination.

This new examination will be available in early 2022, and a Fellowship examination will follow later in the year.

Professor Michael Griffin OBE, President of the RCSEd

Professor Michael Griffin OBE

“We would like to thank the ICO for the very positive relationship we have enjoyed over the last few years and wish them the best in their pursuit of improving standards in global Ophthalmology care,” said Professor Michael Griffin OBE, President of the RCSEd. “We are delighted to now have the opportunity to launch our very own MRCS Ophthalmology and look forward to adding a Fellowship examination next year, ensuring those in the profession will have a continued route into College membership.”

RCSEd was first incorporated as the Barber Surgeons of Edinburgh in 1505, and it has since grown to nearly 29,000 members from 100 countries worldwide, with 15,000 in the UK. As one of the oldest surgical corporations in the world, the College promotes the high standards in surgical and dental practice. The College is also home of the UK’s only Faculty of Surgical Trainers, which is open to anyone with interest in surgical training, regardless of College affiliation.

All ICO College Members—including the April intake of this year—are eligible for the full benefits and services the College offers.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.